Colorectal cancer (CRC) typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous. Globally, CRC is the third most common type of cancer, making up about 10% of all cases. Most CRCs are due to old age and lifestyle factors, as well as to cancer family history. The main risk factors include diet, obesity, smoking, alcohol, lack of physical activity, inflammatory bowel disease, adenomatous polyposis, and hereditary non-polyposis colon cancer.
Treatments may include surgery, radiotherapy, chemotherapy, and targeted therapy. The five-year survival rate in the United States is around 65%. Accumulative evidence has demonstrated that mucosa-associated bacteria harbor pro-tumoral properties, supporting an active role of bacteria as pathobionts. Some of the most relevant protumoral pathobionts are Escherichia coli, Fusobacterium nucleatum, and Bacteroides fragilis.
Total samples: | 534 |
---|---|
Females: | 196 |
Males: | 333 |
Age: | 63.9 (28-90) |
BMI: | 24.5 (13.3-40.0) |
Enriched in | 225 species |
---|---|
Depleted in | 38 species |
hgma11 - CRC - United States of America
hgma399 - CRC - France
hgma412 - CRC - Austria
hgma413 - CRC - China
hgma414 - CRC - India
hgma415 - CRC - United Kingdom
hgma44 - CRC - United Kingdom
hgma45 - CRC - Japan
hgma46 - CRC - Italy
PRJDB4176 - 10.1038/s41591-019-0458-7
PRJEB10878 - 10.1136/gutjnl-2015-309800
PRJEB12449 - 10.1371/journal.pone.0155362
PRJEB27928 - 10.1038/s41591-019-0406-6
PRJEB6070 - 10.15252/msb.20145645
PRJEB7774 - 10.1038/ncomms7528
PRJNA447983 - 10.1038/s41591-019-0405-7
PRJNA531273 - 10.1128/mSystems.00438-19